Weekly News Roundup for August 7, 2015
These are some of the stories we’ve been following this week. Since the EB-5 Immigrant Investor Program is up for renewal on September 30, Congress has been considering reforms in the EB-5 visa...
View ArticleValuation of Drug Royalties
Drug royalties are the royalties paid primarily by pharmaceutical companies to academic institutions, scientists, and development stage biotechnology companies for the intellectual property (IP)...
View ArticleGreenfield Advisors Launches Pharmaceutical and Medical Royalty Valuation...
CARTERSVILLE, GA and SEATTLE, WA, JANUARY 13, 2016 – Greenfield Advisors now provides expert medical royalty valuation. The financial and real estate consulting firm saw a need for such services after...
View ArticleThe Marketplace for Pharmaceutical, Medical Device, and Diagnostic Royalties
Without a doubt, one of the fastest growing private equity markets in the last decade has been the market for healthcare product royalties—royalties derived from the end sale of pharmaceuticals,...
View Article
More Pages to Explore .....